IQONE HEALTHCARE SWITZERLAND SA
IQONE HEALTHCARE SWITZERLAND SA is a Originators company based in Versoix (Geneva) recorded by Swissmedic as the authorisation holder for 21 human medicines. That places it 91 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.
Key facts
| Sector | Originators |
|---|---|
| City | Versoix |
| Canton | Geneva |
| Authorisation holder | Yes |
| Medicines | 21 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Not available |
| Activity | Not available |
| Website | iqone-healthcare.com |
Medicines authorised in Switzerland
IQONE HEALTHCARE SWITZERLAND SA is recorded by Swissmedic as the authorisation holder for 21 human medicines. The table shows 21 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
21 of 21 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Avtozma 162 mg/0.9 ml | 69855 | A | L04AC07 | 2025-06-20 |
| Avtozma 162mg/0.9 ml | 69854 | A | L04AC07 | 2025-06-20 |
| Avtozma 80 mg/ 4ml | 69850 | A | L04AC07 | 2025-06-20 |
| Eydenzelt 40 mg / ml | 70216 | B | S01LA05 | 2026-04-10 |
| Eydenzelt 40mg / ml | 70215 | B | S01LA05 | 2026-04-10 |
| Grasustek 6 mg | 68166 | A | L03AA13 | 2021-04-07 |
| Herzuma 440 mg | 67892 | A | L01FD01 | 2021-07-13 |
| Idefirix 11 mg | 68373 | A | L04AA41 | 2022-05-06 |
| Omlyclo 75 mg/0.5 ml | 69508 | B | R03DX05 | 2024-09-26 |
| Osenvelt 120 mg/1.7 ml (70 mg/ml) | 70196 | A | M05BX04 | 2025-08-19 |
| Remsima 100 mg | 65373 | A | L04AB02 | 2015-10-14 |
| Remsima 100 mg | 70236 | A | L04AB02 | 2026-07-03 |
| Steqeyma 130mg / 26mL | 70002 | B | L04AC05 | 2025-04-24 |
| Steqeyma 45mg / 0.5mL | 70003 | B | L04AC05 | 2025-04-24 |
| Stoboclo 60 mg | 70199 | B | M05BX04 | 2025-08-19 |
| Truxima 100 mg/10 ml | 66648 | A | L01FA01 | 2018-09-06 |
| Veblocema | 67887 | A | - | 2021-06-29 |
| Veblocema 120 mg | 67888 | A | L04AB02 | 2021-06-29 |
| Vegzelma 100 mg/4 ml | 69166 | A | L01FG01 | 2023-02-15 |
| Yuflyma 40 mg | 68514 | B | L04AB04 | 2022-06-22 |
| Yuflyma 40 mg | 68515 | B | L04AB04 | 2022-06-22 |
Frequently asked questions
How many medicines does IQONE HEALTHCARE SWITZERLAND SA have authorised in Switzerland?
IQONE HEALTHCARE SWITZERLAND SA is recorded by Swissmedic as the authorisation holder for 21 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is IQONE HEALTHCARE SWITZERLAND SA based?
The Swiss location recorded for IQONE HEALTHCARE SWITZERLAND SA is Versoix, Geneva.
Is IQONE HEALTHCARE SWITZERLAND SA a Swissmedic authorisation holder?
Yes. IQONE HEALTHCARE SWITZERLAND SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.